HALO

HALOZYME THERAPEUTICS INC

Healthcare | Mid Cap

$2.18

EPS Forecast

$462.4

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-03-31
RVMDRevolution Medicines IncCRBUCaribou Biosciences IncIOVAIovance Biotherapeutics IncREPLReplimune Group IncDNLIDenali Therapeutics Inc